Alan Baer Maderazo, VP, Qual, Reg, & Clin Affairs at GenMark Diagnostics, Inc. (GNMK), sold 2,110 shares at $20.36 ($6K) on 2021-02-22, disclosed to the SEC on 2021-02-22.
Scheduled sale ($6k) by VP, Qual, Reg, & Clin Affairs under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,820 | $0 | 0.0% |
| 2 | $20.36 | 290 | $6K | 100.0% |
| Total | $2.80 avg | 2,110 | $6K | 100% |
| Filing → |
| GNMK | SELL | 2021-02-24 | $3K | — | Filing → |
| GNMK | SELL | 2021-01-29 | $189K | — | Filing → |
| GNMK | SELL | 2021-01-25 | $676K | — | Filing → |